Ranju Sarkar And P B Jayakumar

Stories by Ranju Sarkar And P B Jayakumar

Mixed response to Sebi's proposed audit rules

Mixed response to Sebi's proposed audit rules

Rediff.com   22 Sep 2009

In an attempt to avoid Satyam-like frauds, a Sebi panel has suggested rotation of audit partners signing the accounts and giving more teeth to the company's audit committee.

Cipla to develop anti-allergy drug

Cipla to develop anti-allergy drug

Rediff.com   12 Sep 2009

Domestic drug major Cipla Ltd has signed a long-term collaboration agreement with Swiss specialty pharmaceutical major Meda, to develop and market an anti-allergic rhinitis drug for various global markets. Cipla will manufacture the drug, which will treat an ailment that causes a runny nose, and the Swiss company will market the product in Europe, Japan, Brazil, South Korea and Australia. The partners are developing the product as a nasal spray to treat allergic rhinitis.

Piramal makes progress on cancer drug research

Piramal makes progress on cancer drug research

Rediff.com   28 Aug 2009

PLSL's lead molecule under development for cancer treatment has completed two Phase-I studies.

JSW to raise Rs 9,000 cr in 18 months

JSW to raise Rs 9,000 cr in 18 months

Rediff.com   26 Aug 2009

JSW Energy aims to generate 11,390 Mw in the country by 2015. The company has tied up with two consortiums of lenders, led by IDBI Bank and State Bank of India, respectively, for the loans. It had recently filed a draft red-herring prospectus for a Rs 3,000 crore (Rs 30 billion) public offering with market regulator Securities and Exchange Board of India.

Ajanta Pharma, Medicago join hands for flu vaccine

Ajanta Pharma, Medicago join hands for flu vaccine

Rediff.com   21 Aug 2009

Mumbai-based Ajanta Pharma has tied up with the Canadian vaccine maker, Medicago Inc, to commercialise Medicago's pandemic and seasonal influenza vaccines in India and other territories.

Indian generics profit from Glaxo patent expiry

Indian generics profit from Glaxo patent expiry

Rediff.com   18 Aug 2009

GlaxoSmithKline Plc's anti-migraine drug brand, Imitrex, is turning out to be a good revenue earner for Indian generic companies.

Worst seems to have passed for CV makers

Worst seems to have passed for CV makers

Rediff.com   6 Aug 2009

Sales of commercial vehicles, which were on a decline for over a year, are showing signs of a recovery. Two out of the three CV makers reported an increase in sales last month.

Budget carriers fly high in downturn

Budget carriers fly high in downturn

Rediff.com   30 Jul 2009

Low cost carriers have 55 per cent of the market, up from 45 per cent in Q1 last year, and 30 per cent two years back. Does it mean India really is an LCC market? The performance of the airlines also seem to suggest that. While budget carrier Spicejet announced a small profit for Q1, all the big boys in the industry seem to be in trouble.

Asset sale plan: Wockhardt may go slow

Asset sale plan: Wockhardt may go slow

Rediff.com   27 Jul 2009

Sources said the company had already secured the required funds for payments due during the current year and might wait for higher valuations for assets that were on the block. Under the CDR, Wockhardt has to divest its non-core assets at an estimated value of Rs 790 crore (Rs 7.9 billion), but the company has been given six years to complete the transaction.

India Inc finds wealth in health

India Inc finds wealth in health

Rediff.com   27 Jul 2009

With entrepreneurs like Maganti drawing up aggressive plans, India has added 10,000 to 15,000 beds every year over the past five years.

Indian pharma firms swallow bitter pill in US, EU

Indian pharma firms swallow bitter pill in US, EU

Rediff.com   16 Jul 2009

Regulators tighten net on safety grounds.

ArcelorMittal's Rs 40,000-cr project put on hold

ArcelorMittal's Rs 40,000-cr project put on hold

Rediff.com   15 Jul 2009

However, the company will go ahead with its plans in Jharkhand, and has secured iron ore mines and coal linkages to the project, company sources told Business Standard. An e-mail reply from the steel major said it was not expecting its projects in India to start before 2014.

Wockhardt gets CDR lifeline, with riders

Wockhardt gets CDR lifeline, with riders

Rediff.com   10 Jul 2009

Wockhardt Chairman Habil Khorakiwala can breathe easy, as bankers have approved the debt restructuring package he had sought three months ago.

Valuation concerns slow down QIPs

Valuation concerns slow down QIPs

Rediff.com   6 Jul 2009

More than 50 companies had rushed to make qualified institutional placements after real estate firms like Unitech and Indiabulls raised money through this route. Now it appears that only some of these companies may be able to raise equity through this route, on rising concerns over valuations and over-supply.

Fortis rights' issue for Rs 1,000 cr in a month

Fortis rights' issue for Rs 1,000 cr in a month

Rediff.com   1 Jul 2009

Fortis Healthcare, promoted by former Ranbaxy owners Malvinder Singh and Shivinder Singh, will raise Rs 1,000 crore (Rs 10 billion) through a rights issue by the first week of August, to fund its expansion plan.

Tata Power to snap supply to R-Infra

Tata Power to snap supply to R-Infra

Rediff.com   26 Jun 2009

It will focus on sourcing 800 Mw for BEST and 477 Mw for its own distribution system from April '10. Sources said TPC on Thursday officially wrote a letter on the issue to R-Infra, informing them that it would support the ADA group company till March next year in the interest of Mumbai's consumers, and help R-Infra find alternative arrangements. While a Tata Power spokesperson declined to comment, an R-Infra spokesperson expressed surprise over the decision.

Wal-Mart faces ire over Ranbaxy drugs

Wal-Mart faces ire over Ranbaxy drugs

Rediff.com   26 Jun 2009

WakeupWalmart.com, an anti-Wal-Mart website which belongs to the United Food and Commercial Workers Union, came out with a report two days ago titled, 'Wal-Mart's vaunted $4 prescriptions supplied by disgraced Indian manufacturer.' UFCW claims to have a membership of over 1.3 million workers in the US and Canada. WakeupWalmart.com mainly campaigns for the rights of Wal-Mart employees and consumer interests.

Reliance Infrastructure looks at domestic banks

Reliance Infrastructure looks at domestic banks

Rediff.com   19 Jun 2009

The Anil Dhirubhai Ambani group company hasn't yet got the contract for executing the second phase of the Mumbai Metro, but Jalan's team has already started negotiating with domestic banks to tie up funds for the estimated Rs 11,000-crore (Rs 110-billion) project.

Cheaper gas: fillip to R-Power's Dadri project

Cheaper gas: fillip to R-Power's Dadri project

Rediff.com   16 Jun 2009

Reliance Power's plans are to set up a 7,480-Mw project, which will be the largest gas-fired power project at a single location in the world.

Wal-Mart's secret of success amid slump

Wal-Mart's secret of success amid slump

Rediff.com   8 Jun 2009

The annual shareholders' meet resembled a rock concert in an indoor stadium with associates cheering like crazy fans.